ClinicalTrials.gg
Sign In

Leukemia, Myelomonocytic, Chronic clinical trials

The registry lists 540 studies for Leukemia, Myelomonocytic, Chronic across more than 10 countries. 69 are recruiting or about to start. 85 of them are mainly about Leukemia, Myelomonocytic, Chronic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.

ClinicalTrials.gov finds 624 studies for Leukemia, Myelomonocytic, Chronic. How that becomes 540 here

This page counts the studies the registry files under Leukemia, Myelomonocytic, Chronic, and those it files under no condition that list Leukemia, Myelomonocytic, Chronicthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 624Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −9List Leukemia, Myelomonocytic, Chronic as a condition, but the registry did not file them under itMost often written as “Chronic Myelomonocytic Leukemia-2” (4), “Chronic Myelomonocytic Leukemia in Remission” (1), and “Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic Leukemia” (1). The registry filed them under other conditions only, most often Myelodysplastic Syndromes (6) and Leukemia, Myeloid, Acute (5).
  3. −75Match it another way13 name it in the title, 3 in a keyword, and 59 by a synonym or other text the search reads.
  4. 540The count on this page

Get an email when these change. Save the Leukemia, Myelomonocytic, Chronic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
316
Terminated
79
Recruiting
63
Active, not recruiting
36
Withdrawn
22
Status unknown
15

Phase

Phase 2
264
Phase 1
232
Phase 3
45
Early Phase 1
4

Where

United States
441
France
46
Germany
40
Canada
33
Italy
31
Spain
28

Who runs them

M.D. Anderson Cancer Center (53) · Fred Hutchinson Cancer Center (45) · National Cancer Institute (NCI) (41) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (21) · Memorial Sloan Kettering Cancer Center (15) · City of Hope Medical Center (13) · Roswell Park Cancer Institute (12) · Case Comprehensive Cancer Center (11)

What is being tested here

Drugs under test in Leukemia, Myelomonocytic, Chronic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cyclophosphamide6454
Fludarabine6254
Venetoclax4113
Fludarabine phosphate3245
Azacitidine3338
Tacrolimus3022
Decitabine3322
Cytarabine3018
Pacritinib306
Busulfan2433

Drug classes tested here Antimetabolites 16 open · Tyrosine kinase inhibitors (TKIs) 12 open · Alkylating agents 10 open · JAK inhibitors 6 open · Calcineurin inhibitors 5 open

Coming up

5phase 3 studies under way
39studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 63 Leukemia, Myelomonocytic, Chronic studies recruiting now, 47 (75%) set no upper age limit and 7 (11%) stop at 75 or younger. 8 (13%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (6%) take healthy volunteers.

Recruiting studies that take each age, of 63
AgeWomenMen
103 (5%)3 (5%)
1862 (98%)62 (98%)
3062 (98%)62 (98%)
4062 (98%)62 (98%)
5062 (98%)62 (98%)
6562 (98%)62 (98%)
7559 (94%)59 (94%)
8550 (79%)50 (79%)

Across all 540 studies, recruiting or not: 23% stop at 75 or younger and 14% at 65; 28% take children; 0% are for women only and <1% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Leukemia, Myelomonocytic, Chronic studies take

Of 69 phase 2 interventional studies under Leukemia, Myelomonocytic, Chronic, half reached primary completion within 68 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 151 mo31–74 · 66 studies—51 mo35–90 · 43 studies
Phase 1/2106 mo64–112 · 36 studies——
Phase 268 mo46–110 · 69 studies—70 mo46–111 · 62 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Stopped1

Studies

Recruiting first, then most recently updated. Showing 50 of 540. Browse all 540 → or search them.